- Home
- BLDR vs MRNA Comparison
BLDR vs MRNA Comparison
Compare BLDR & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDR
- MRNA
- Stock Information
- Founded
- BLDR 1998
- MRNA 2010
- Country
- BLDR United States
- MRNA United States
- Employees
- BLDR N/A
- MRNA N/A
- Industry
- BLDR RETAIL: Building Materials
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BLDR Consumer Discretionary
- MRNA Health Care
- Exchange
- BLDR Nasdaq
- MRNA Nasdaq
- Market Cap
- BLDR 14.3B
- MRNA 16.0B
- IPO Year
- BLDR 2005
- MRNA 2018
- Fundamental
- Price
- BLDR $116.94
- MRNA $24.72
- Analyst Decision
- BLDR Strong Buy
- MRNA Hold
- Analyst Count
- BLDR 19
- MRNA 20
- Target Price
- BLDR $185.37
- MRNA $54.47
- AVG Volume (30 Days)
- BLDR 1.9M
- MRNA 10.2M
- Earning Date
- BLDR 05-01-2025
- MRNA 05-01-2025
- Dividend Yield
- BLDR N/A
- MRNA N/A
- EPS Growth
- BLDR N/A
- MRNA N/A
- EPS
- BLDR 9.06
- MRNA N/A
- Revenue
- BLDR $16,400,491,999.00
- MRNA $3,236,000,000.00
- Revenue This Year
- BLDR $4.29
- MRNA N/A
- Revenue Next Year
- BLDR $5.14
- MRNA $22.07
- P/E Ratio
- BLDR $12.91
- MRNA N/A
- Revenue Growth
- BLDR N/A
- MRNA N/A
- 52 Week Low
- BLDR $110.84
- MRNA $23.15
- 52 Week High
- BLDR $203.14
- MRNA $170.47
- Technical
- Relative Strength Index (RSI)
- BLDR 41.47
- MRNA 36.68
- Support Level
- BLDR $112.27
- MRNA $23.68
- Resistance Level
- BLDR $124.00
- MRNA $27.21
- Average True Range (ATR)
- BLDR 7.32
- MRNA 2.06
- MACD
- BLDR -0.08
- MRNA -0.03
- Stochastic Oscillator
- BLDR 29.79
- MRNA 26.98
About BLDR Builders FirstSource Inc.
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.